E About
EvolutionaryScale develops generative AI models for de novo protein design and understanding, most notably the ESM-3 family of protein language models. Their core innovation lies in leveraging large-scale protein sequence data to enable the creation of novel proteins with desired functions – demonstrated by the successful in silico design and synthesis of esmGFP, a fluorescent protein evolved beyond natural limitations. Targeting pharmaceutical companies, biotechnology firms, and academic research labs, EvolutionaryScale provides access to ESM-3 via API and open-source models (ESM-3-open) to accelerate drug discovery and protein engineering efforts, backed by $142M in seed funding.
Focus Areas
Technology Focus
Key People 1
- Alex Rives
Quick Stats
- Total Raised
- $142M
- Founded
- 2024
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
Lila Sciences
San Francisco, United States
Cradle
Amsterdam, Netherlands
FinalDose
London, United Kingdom
Aqemia
Paris, France